Disclosures for "The Effect of Ecopipam and its Metabolites on Cardiac Repolarization, QTcF "
-
Dr. Wanaski has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Wanaski has stock in Paragon Biosciences. Dr. Wanaski has stock in Emalex Biosciences.
-
Dr. Xue has nothing to disclose.
-
Dr. Darpo has stock in Clario.
-
Author has nothing to disclose
-
Dr. Cunniff has received personal compensation for serving as an employee of Paragon Biosciences. Dr. Cunniff has stock in Harmony Biosciences. Dr. Cunniff has stock in Emalex Biosciences.
-
Dr. Munschauer has received personal compensation for serving as an employee of Emalex Biosciences. Dr. Munschauer has stock in Emalex Biosciences.
-
Author has nothing to disclose
-
Dr. Schmith has received personal compensation in the range of $100,000-$499,999 for serving as a Consultant for Emalex Biosciences.